Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1994
Fusarium infections in immunocompromised patients: case reports and literature reviewM Rabodonirina, M A Piens, M F Monier, et al.
Nouvelle Revue Francaise D'Hematologie|November 25, 1978
[Prognostic value of delayed-hypersensitivity skin tests and rosette studies in acute non-lymphoid leukemias]H Vu Van, J P Révillard, J Brochier, et al.
Leukemia|January 22, 1998
Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpointE Archimbaud, C Charrin, J P Magaud, et al.
Leukemia|March 1, 1996
Expression of BCL-2 proto-oncogene in adult acute lymphoblastic leukemiaL Campos, O Sabido, C Sebban, et al.
Cancer|July 1, 1983
Dysmyelopoietic syndromes. A search for prognostic factors in 193 patientsB Coiffier, P Adeleine, J J Viala, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Cellular pharmacokinetics of daunorubicin: uptake by leukaemic cells in vivo and fateV Trillet, M Lakhal, J Lang, et al.
Blood|September 1, 1983
Comparison of chemotherapy with immunotherapy for maintenance of acute lymphoblastic leukemia in children and adultsP A Stryckmans, J Otten, M J Delbeke, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|April 8, 1979
[Treatment of 100 acute myeloid leukemias (author's transl)]D Fière, C Martin, H Vu Van, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1982
Agar culture of bone marrow cells in acute myeloid leukemia and dysmyelopoietic syndromes. Reevaluation of its prognostic valueB Coiffier, P A Bryon, D Fière, et al.
Blood|March 1, 1989
Alternating v repeated postremission treatment in adult acute myelogenous leukemia: a randomized phase III study (AML6) of the EORTC Leukemia Cooperative GroupR Zittoun, U Jehn, D Fière, et al.
Pageof 5